Blog Viewer

Lilly to sell reduced price insulin lispro

By Nathan Painter posted 05-23-2019 10:43

  

On Monday, March 4, Lilly Diabetes announced in a press release that an authorized generic version of Humalog insulin will be available in United States pharmacies for half the list price of Humalog.

Called Insulin Lispro, the generic version will be identical to rapid-acting Humalog, mirroring both its structure and function. The list price of one vial will be $137.35 and the price of a box of five pens will be $265.20. According to Lilly’s announcement, these products have already been manufactured and they plan to make them available in pharmacies around the United States quickly. Insulin Lispro will be sold under ImClone Systems, a Lilly subsidiary.

Insulin Lispro will be available to patients who take Humalog without an additional prescription from a doctor. Patients will be able to speak directly with a pharmacist to determine whether Humalog or Insulin Lispro is a more cost effective option for them.

Read more here: https://beyondtype1.org/new-generic-insulin-launched/?fbclid=IwAR3QAb2N0ixfA3bNIcKSGP8AzFswqBuYS4G88CExsKsWFiDSXTNMzf6CRdg 

1 comment
0 views

Comments

Lisa Laird
05-23-2019 13:50

Lilly to sell reduced price insulin

Thanks Nathan!  Our residents discharged a patient today; I called his pharmacy and the cost was $519 for Humalog Kwikpens. I was able to use a voucher card for today, but your information will benefit his future access to insulin. No other rapid acting was any less expensive or preferred. The patient will be encouraged to register online for other options directly from the manufacturer.